CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Scienta Lab is developing an artificial intelligence model to improve drug development in immunology and inflammation. This technology aims to enhance preclinical testing and increase the success rates of clinical trials for new therapies.
The immune system and its disorders are particularly complex to model, posing significant challenges for drug development.
Due tothe limited representativeness of preclinical models, nearly half of clinical trial failures in immunology and inflammation stem frominsufficient efficacy.The rise of artificial intelligence capabilities offers a transformative opportunity to address this issue.
With the support of the EICAccelerator project, France-based start-up Scienta Lab aims to develop a propriet…
SCIENTA LAB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.